Literature DB >> 2476575

Class I major histocompatibility proteins as cell surface receptors for simian virus 40.

W J Atwood1, L C Norkin.   

Abstract

Class I major histocompatibility complex proteins appear to be the major cell surface receptors for simian virus 40 (SV40), as implied by the following observations. Adsorption of SV40 to LLC-MK2 rhesus monkey kidney cells specifically inhibited binding of a monoclonal antibody (MAb) against class I human lymphocyte antigen (HLA) proteins. Conversely, pretreatment of LLC-MK2 cells with anti-HLA MAbs inhibited infection by SV40. The ability of anti-HLA to inhibit infection was greatly reduced when the order of addition of the anti-HLA and the virus was reversed. Infection was also inhibited by preincubating SV40 with purified soluble class I protein. Finally, human lymphoblastoid cells of the Daudi line, which do not express class I major histocompatibility complex proteins, were infected at relatively low levels with SV40 virions. In a control experiment, we found that pretreatment of cells with a MAb specific for the leukocytic-function-associated antigen LFA-3 actually enhanced infection. This finding may also support the premise that class I major histocompatibility complex proteins are receptors for SV40.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2476575      PMCID: PMC251073     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  Interaction between CD4 and class II MHC molecules mediates cell adhesion.

Authors:  C Doyle; J L Strominger
Journal:  Nature       Date:  1987 Nov 19-25       Impact factor: 49.962

2.  Structure of a human common cold virus and functional relationship to other picornaviruses.

Authors:  M G Rossmann; E Arnold; J W Erickson; E A Frankenberger; J P Griffith; H J Hecht; J E Johnson; G Kamer; M Luo; A G Mosser
Journal:  Nature       Date:  1985 Sep 12-18       Impact factor: 49.962

3.  Direct evidence for a receptor-ligand interaction between the T-cell surface antigen CD2 and lymphocyte-function-associated antigen 3.

Authors:  Y Takai; M L Reed; S J Burakoff; S H Herrmann
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

4.  Monoclonal antibody to SV40 T-antigen blocks lysis of cloned cytotoxic T-cell line specific for SV40 TASA.

Authors:  S Pan; B B Knowles
Journal:  Virology       Date:  1983-02       Impact factor: 3.616

5.  The functional significance, distribution, and structure of LFA-1, LFA-2, and LFA-3: cell surface antigens associated with CTL-target interactions.

Authors:  A M Krensky; F Sanchez-Madrid; E Robbins; J A Nagy; T A Springer; S J Burakoff
Journal:  J Immunol       Date:  1983-08       Impact factor: 5.422

Review 6.  Papovaviral persistent infections.

Authors:  L C Norkin
Journal:  Microbiol Rev       Date:  1982-12

7.  T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV.

Authors:  D Klatzmann; E Champagne; S Chamaret; J Gruest; D Guetard; T Hercend; J C Gluckman; L Montagnier
Journal:  Nature       Date:  1984 Dec 20-1985 Jan 2       Impact factor: 49.962

8.  Biology of simian virus 40 (SV40) transplantation antigen (TrAg). VI. Mechanism of induction of SV40 transplantation immunity in mice by purified SV40 T antigen (D2 protein).

Authors:  S S Tevethia; D C Flyer; R Tjian
Journal:  Virology       Date:  1980-11       Impact factor: 3.616

9.  The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus.

Authors:  A G Dalgleish; P C Beverley; P R Clapham; D H Crawford; M F Greaves; R A Weiss
Journal:  Nature       Date:  1984 Dec 20-1985 Jan 2       Impact factor: 49.962

10.  Recognition by cytotoxic T lymphocytes of cells expressing fragments of the SV40 tumor antigen.

Authors:  L R Gooding; K A O'Connell
Journal:  J Immunol       Date:  1983-11       Impact factor: 5.422

View more
  39 in total

1.  Caveolae are involved in the trafficking of mouse polyomavirus virions and artificial VP1 pseudocapsids toward cell nuclei.

Authors:  Z Richterová; D Liebl; M Horák; Z Palková; J Stokrová; P Hozák; J Korb; J Forstová
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

Review 2.  Simian virus 40 transformation, malignant mesothelioma and brain tumors.

Authors:  Fang Qi; Michele Carbone; Haining Yang; Giovanni Gaudino
Journal:  Expert Rev Respir Med       Date:  2011-10       Impact factor: 3.772

3.  Bound simian virus 40 translocates to caveolin-enriched membrane domains, and its entry is inhibited by drugs that selectively disrupt caveolae.

Authors:  H A Anderson; Y Chen; L C Norkin
Journal:  Mol Biol Cell       Date:  1996-11       Impact factor: 4.138

4.  Major histocompatibility complex class I molecules mediate association of SV40 with caveolae.

Authors:  E Stang; J Kartenbeck; R G Parton
Journal:  Mol Biol Cell       Date:  1997-01       Impact factor: 4.138

5.  Involvement of cytoskeletal components in BK virus infectious entry.

Authors:  Sylvia Eash; Walter J Atwood
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

Review 6.  Emergent human pathogen simian virus 40 and its role in cancer.

Authors:  Regis A Vilchez; Janet S Butel
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

Review 7.  The evolution of small DNA viruses of eukaryotes: past and present considerations.

Authors:  F F Shadan; L P Villarreal
Journal:  Virus Genes       Date:  1995       Impact factor: 2.332

8.  Structural basis of GM1 ganglioside recognition by simian virus 40.

Authors:  Ursula Neu; Karin Woellner; Guenter Gauglitz; Thilo Stehle
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-19       Impact factor: 11.205

Review 9.  Simian virus 40 and its association with human lymphomas.

Authors:  Regis A Vilchez; Janet S Butel
Journal:  Curr Oncol Rep       Date:  2003-09       Impact factor: 5.075

10.  Caveolae-mediated entry of Salmonella typhimurium into senescent nonphagocytotic host cells.

Authors:  Jae Sung Lim; Hyon E Choy; Sang Chul Park; Jung Min Han; Ik-Soon Jang; Kyung A Cho
Journal:  Aging Cell       Date:  2010-01-20       Impact factor: 9.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.